Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.Journal of neuroscience methods · 2026-11-01Single-crystal structure determination of psilocybin after dehydrationActa Crystallographica Section C Structural Chemistry · 2026-09-01Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.Molecular psychiatry · 2026-07-28An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-07-24PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-07-10α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in miceMolecular Psychiatry · 2026-07-07Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-12The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-08Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanismsNeuropharmacology · 2026-05-01Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.Journal of psychopharmacology (Oxford, England) · 2026-05-01Effects of psychedelic use on authoritarian attitudes revisited.Journal of psychopharmacology (Oxford, England) · 2026-05-01Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome.Chembiochem: a European journal of chemical biology · 2026-04-28The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.ClinicalTrials.gov · 2026-03-24Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase).Psychiatry research · 2026-03-01Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-25Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.Research square · 2026-02-12Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-01-12A lexicon for psychedelic research and treatmentDrug Science Policy and Law · 2025-08-31Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage PatternsJournal of Public Policy & Marketing · 2025-07-16Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome.Chembiochem: a European journal of chemical biology · 2025-07-11Beyond prohibition: A public health analysis of naturalistic psychedelic useJournal of Psychedelic Studies · 2025-07-03Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.The journal of headache and pain · 2025-05-23In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025-05-22Identifying Three Psilocybin Use Patterns by Frequency and Quantity.Journal of studies on alcohol and drugs · 2025-05-01ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report.Psychiatry research · 2025-03-01Psychedelic Medicine Exceptionalism.The American journal of bioethics: AJOB · 2025-01-01Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.Journal of clinical psychopharmacology · 2025-01-01Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial.General hospital psychiatry · 2025-01-01The Neurobiological Effect of 5-HT2AR ModulationClinicalTrials.gov · 2024-12-16Psilocybin for clinical indications: A scoping review.Journal of psychopharmacology (Oxford, England) · 2024-10-01The Epidemiology of Psychedelic Use Among United States Military VeteransJournal of Psychoactive Drugs · 2024-09-12Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse: A Cautionary Tale.The Journal of clinical psychiatry · 2024-08-26Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2024-07-24Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility StudyClinicalTrials.gov · 2024-07-12Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.Trials · 2024-07-03Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.Cancer · 2024-04-01Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08Cannabis and Psilocybin: Insurance Reimbursement, Legalization, and ReschedulingHealth Law Outlook · 2024-01-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.Wellcome open research · 2024-01-01Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?Research Directions Depression · 2023-10-13Psilocybin Use in Palliative Care #464Journal of Palliative Medicine · 2023-09-01Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.Nature neuroscience · 2023-06-01The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24The varieties of psychedelic law.Neuropharmacology · 2023-03-15Therapeutic potential of psilocybin: a promising agent in treating major depressive disorderAIDASCO Reviews · 2023-01-17Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?Journal of Humanistic Psychology · 2022-08-18Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging StudyClinicalTrials.gov · 2022-08-10Genetic Survey of Psilocybe Natural Products.Chembiochem: a European journal of chemical biology · 2022-07-19The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Psychiatry research · 2022-07-01Exploratory review of psilocybin usage and awareness amongst college students and potential consumer goods tradeoffs resulting from increased usageInternational Journal of Research in Marketing Management and Sales · 2022-01-01Examining attitudes to psilocybin: Should candidates for medical psilocybin be required to pass a contextual suitability testPsyArXiv · 2021-11-23Further development of a liquid chromatography-high-resolution mass spectrometry/mass spectrometry-based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestions.Drug testing and analysis · 2021-09-01Mit Psilocybin gegen DepressionInFo Neurologie + Psychiatrie · 2021-08-01Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signalingThe FASEB Journal · 2021-05-01Psychedelics and Psychedelic-Assisted Psychotherapy.Focus (American Psychiatric Publishing) · 2021-01-01Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.Frontiers in pharmacology · 2021-01-01Patents on Psychedelics: The Next Legal Battlefront of Drug DevelopmentSSRN Electronic Journal · 2020-12-31S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in "Magic" Mushrooms.Chembiochem: a European journal of chemical biology · 2020-05-04Psychedelics and Psychedelic-Assisted Psychotherapy.The American journal of psychiatry · 2020-05-01Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to PsychedelicsProceedings of the 2020 CHI Conference on Human Factors in Computing Systems · 2020-04-20Injury-Triggered Blueing Reactions of Psilocybe “Magic” MushroomsAngewandte Chemie · 2019-11-14Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?Pain management · 2018-05-01Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2018-02-01Psychedelic Medicine for Mental Illness and Substance Use Disorders: Overcoming Social and Legal ObstaclesSSRN Electronic Journal · 2017-11-02Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific reports · 2017-10-13Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The lancet. Psychiatry · 2016-07-01Lysergic Acid Diethylamide and Psilocybin Revisited.Biological psychiatry · 2015-10-15Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.Molecular & cellular proteomics: MCP · 2014-05-01Serotonergic hallucinogens as translational models relevant to schizophrenia.The international journal of neuropsychopharmacology · 2013-11-01Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2012-02-01Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.Journal of psychopharmacology (Oxford, England) · 2011-11-01Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.Pharmacogenomics · 2011-02-01The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2007-09-01Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.Journal of psychopharmacology (Oxford, England) · 2007-05-01Increased activation of indirect semantic associations under psilocybin.Biological psychiatry · 1996-06-15Ethnomycology, biochemistry, and cultivation of Psilocybe samuiensis Guzmán, Bandala and Allen, a new psychoactive fungus from Koh Samui, Thailand.Journal of ethnopharmacology · 1994-07-08